Elixir Capital Limited has submitted a regulatory filing to BSE Limited regarding an upcoming Board of Directors meeting. The meeting is scheduled to be held on Thursday, 13th August, 2026 at the company's Registered Office.
The primary agenda items for the board meeting include:
- Approval and taking on record of the Un-Audited Financial Results (Standalone and Consolidated) for the quarter ended 30th June, 2026
- Consideration of any other business with the permission of the Chair
The company had previously intimated to the Exchange on 25th June, 2026 that the trading window for dealing in securities of the Company has been closed since Wednesday, 1st July, 2026. This closure is specifically for the consideration of Un-Audited Financial Results for the quarter ended 30th June, 2026. The trading window will reopen 48 hours after the declaration of these financial results.
This notice is formally submitted pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The document is digitally signed by Radhika Dipan Mehta, Whole-Time Director of Elixir Capital Limited, on August 3, 2026, at 12:47:33 IST.
Financial Impact
No financial results or specific figures are disclosed in this filing. The document serves as advance notice of the board meeting where financial results will be considered and approved.